Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2Phase NA 1Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Gliosarcoma 5Glioblastoma 4Liver Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Pancreatic Neoplasms 2Neoplasm Metastasis 2Carcinoma, Hepatocellular 2Astrocytoma 2Stomach Neoplasms 1Prostatic Neoplasms 1Ovarian Neoplasms 1Melanoma 1Lung Neoplasms 1Head and Neck Neoplasms 1Diffuse Intrinsic Pontine Glioma 1Colorectal Neoplasms 1Colonic Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Ovarian Epithelial 1Breast Neoplasms 1Brain Neoplasms 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

Paclitaxel 6Carboplatin 6Radiotherapy 5Erlotinib Hydrochloride 4pembrolizumab 3aldesleukin 2Nivolumab 2Magnetic Resonance Spectroscopy 2Interleukin-2 2Cyclophosphamide 2Bevacizumab 2veliparib 1trametinib 1spartalizumab 1satraplatin 1osimertinib 1onartuzumab 1nintedanib 1methyl-4-fluoro-4-deoxyglucose 1fludarabine phosphate 1fludarabine 1bemarituzumab 1anlotinib 1aflutinib 1Taxes 1Sorafenib 1Sirolimus 1Radiotherapy, Conformal 1Radiosurgery 1Pentostatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Adenocarcinoma of Lung × Radiotherapy, Conformal × Clear all
NCT01386385 2026-05-26

Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

National Cancer Institute (NCI)

Phase 1/2 Active not recruiting
53 enrolled 21 charts
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar

Data powered by HemOnc (CC BY 4.0) Colophon âš¡